A detailed history of Us Bancorp \De\ transactions in Organon & Co. stock. As of the latest transaction made, Us Bancorp \De\ holds 37,358 shares of OGN stock, worth $556,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,358
Previous 37,712 0.94%
Holding current value
$556,260
Previous $780,000 8.46%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$18.65 - $23.03 $6,602 - $8,152
-354 Reduced 0.94%
37,358 $714,000
Q2 2024

Aug 06, 2024

SELL
$17.45 - $21.96 $20,887 - $26,286
-1,197 Reduced 3.08%
37,712 $780,000
Q1 2024

May 07, 2024

BUY
$13.78 - $18.8 $5,952 - $8,121
432 Added 1.12%
38,909 $731,000
Q4 2023

Feb 09, 2024

BUY
$10.95 - $17.32 $24,462 - $38,692
2,234 Added 6.16%
38,477 $554,000
Q3 2023

Nov 03, 2023

SELL
$16.59 - $23.77 $101,331 - $145,187
-6,108 Reduced 14.42%
36,243 $629,000
Q2 2023

Aug 09, 2023

SELL
$19.27 - $24.63 $91,185 - $116,549
-4,732 Reduced 10.05%
42,351 $881,000
Q1 2023

May 09, 2023

SELL
$21.42 - $32.08 $75,184 - $112,600
-3,510 Reduced 6.94%
47,083 $1.11 Million
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $118,927 - $145,968
-5,102 Reduced 9.16%
50,593 $1.41 Million
Q3 2022

Oct 27, 2022

SELL
$23.4 - $34.25 $456,487 - $668,149
-19,508 Reduced 25.94%
55,695 $1.3 Million
Q2 2022

Aug 01, 2022

SELL
$31.66 - $38.9 $140,475 - $172,599
-4,437 Reduced 5.57%
75,203 $2.54 Million
Q1 2022

May 11, 2022

SELL
$30.45 - $39.36 $375,753 - $485,702
-12,340 Reduced 13.42%
79,640 $2.78 Million
Q4 2021

Feb 11, 2022

SELL
$28.67 - $37.13 $685,069 - $887,221
-23,895 Reduced 20.62%
91,980 $2.8 Million
Q3 2021

Nov 10, 2021

SELL
$28.63 - $35.64 $1.41 Million - $1.75 Million
-49,181 Reduced 29.8%
115,875 $3.8 Million
Q2 2021

Aug 05, 2021

BUY
$28.45 - $38.0 $4.7 Million - $6.27 Million
165,056 New
165,056 $5 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.79B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.